| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9227171 | Journal of Allergy and Clinical Immunology | 2005 | 8 Pages |
Abstract
FAHF-2 treatment completely eliminated anaphylaxis in mice allergic to peanut challenged as long as 5 weeks posttherapy. This result was associated with downregulation of TH2 responses. FAHF-2 may be a potentially effective and safe therapy for peanut allergy.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Kamal D. MPhil, Jacob D. BS, Zhong Mei PhD, Jing Hua MD, Libang MD, Sylvan PhD, Joseph PhD, Hugh A. MD, Xiu-Min MD,